The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China. (2021)

First Author: Weerasuriya CK
Attributed to:  Mathematical modelling to accelerate development of critical new Tuberculosis vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12916-021-01932-7

PubMed Identifier: 33632218

Publication URI: http://europepmc.org/abstract/MED/33632218

Type: Journal Article/Review

Volume: 19

Parent Publication: BMC medicine

Issue: 1

ISSN: 1741-7015